Cargando…
Analyzing the Association of Visceral Adipose Tissue Growth Differentiation Factor-15 and MicroRNA in Type 2 Diabetes Mellitus
BACKGROUND: Growth differentiation factor-15 (GDF-15) is involved in insulin resistance and diabetes. In this study, we determine the associations of GDF-15 with miR-181b-5p, miR-330-3p, mothers against decapentaplegic homolog 7 (SMAD7), and insulin resistance in visceral adipose tissue (VAT) and pe...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for the Study of Obesity
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088550/ https://www.ncbi.nlm.nih.gov/pubmed/36918405 http://dx.doi.org/10.7570/jomes22010 |
_version_ | 1785022593920663552 |
---|---|
author | Roy, Dipayan Purohit, Purvi Khokhar, Manoj Modi, Anupama Shukla, Ravindra Kumar Gayaprasad Chaudhary, Ramkaran Sankanagoudar, Shrimanjunath Sharma, Praveen |
author_facet | Roy, Dipayan Purohit, Purvi Khokhar, Manoj Modi, Anupama Shukla, Ravindra Kumar Gayaprasad Chaudhary, Ramkaran Sankanagoudar, Shrimanjunath Sharma, Praveen |
author_sort | Roy, Dipayan |
collection | PubMed |
description | BACKGROUND: Growth differentiation factor-15 (GDF-15) is involved in insulin resistance and diabetes. In this study, we determine the associations of GDF-15 with miR-181b-5p, miR-330-3p, mothers against decapentaplegic homolog 7 (SMAD7), and insulin resistance in visceral adipose tissue (VAT) and peripheral blood mononuclear cells (PBMCs) in type 2 diabetes mellitus (T2DM) patients. METHODS: Sixty patients, equally divided into those with T2DM and non-diabetic controls, were recruited for gene expression analysis. Protein-protein interaction (STRING), target prediction (miRNet), and functional enrichment were conducted accordingly. RESULTS: Our study showed that VAT and PBMCs had similar expression profiles, where GDF-15 and miR-181b-5p were upregulated, whereas SMAD7 and miR-330-3p were downregulated. Serum GDF-15 could differentiate between T2DM and non-diabetic patients (P<0.001). Target prediction revealed a microRNA (miRNA)-messenger RNA regulatory network, transcription factors, and functional enrichment for the miRNA that suggested involvement in T2DM pathogenesis. CONCLUSION: VAT GDF-15 is associated with insulin resistance and is possibly regulated by miR-181b-5p, miR-330-3p, and SMAD7 in T2DM. |
format | Online Article Text |
id | pubmed-10088550 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Korean Society for the Study of Obesity |
record_format | MEDLINE/PubMed |
spelling | pubmed-100885502023-04-12 Analyzing the Association of Visceral Adipose Tissue Growth Differentiation Factor-15 and MicroRNA in Type 2 Diabetes Mellitus Roy, Dipayan Purohit, Purvi Khokhar, Manoj Modi, Anupama Shukla, Ravindra Kumar Gayaprasad Chaudhary, Ramkaran Sankanagoudar, Shrimanjunath Sharma, Praveen J Obes Metab Syndr Original Article BACKGROUND: Growth differentiation factor-15 (GDF-15) is involved in insulin resistance and diabetes. In this study, we determine the associations of GDF-15 with miR-181b-5p, miR-330-3p, mothers against decapentaplegic homolog 7 (SMAD7), and insulin resistance in visceral adipose tissue (VAT) and peripheral blood mononuclear cells (PBMCs) in type 2 diabetes mellitus (T2DM) patients. METHODS: Sixty patients, equally divided into those with T2DM and non-diabetic controls, were recruited for gene expression analysis. Protein-protein interaction (STRING), target prediction (miRNet), and functional enrichment were conducted accordingly. RESULTS: Our study showed that VAT and PBMCs had similar expression profiles, where GDF-15 and miR-181b-5p were upregulated, whereas SMAD7 and miR-330-3p were downregulated. Serum GDF-15 could differentiate between T2DM and non-diabetic patients (P<0.001). Target prediction revealed a microRNA (miRNA)-messenger RNA regulatory network, transcription factors, and functional enrichment for the miRNA that suggested involvement in T2DM pathogenesis. CONCLUSION: VAT GDF-15 is associated with insulin resistance and is possibly regulated by miR-181b-5p, miR-330-3p, and SMAD7 in T2DM. Korean Society for the Study of Obesity 2023-03-30 2023-03-15 /pmc/articles/PMC10088550/ /pubmed/36918405 http://dx.doi.org/10.7570/jomes22010 Text en Copyright © 2023 Korean Society for the Study of Obesity https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Roy, Dipayan Purohit, Purvi Khokhar, Manoj Modi, Anupama Shukla, Ravindra Kumar Gayaprasad Chaudhary, Ramkaran Sankanagoudar, Shrimanjunath Sharma, Praveen Analyzing the Association of Visceral Adipose Tissue Growth Differentiation Factor-15 and MicroRNA in Type 2 Diabetes Mellitus |
title | Analyzing the Association of Visceral Adipose Tissue Growth Differentiation Factor-15 and MicroRNA in Type 2 Diabetes Mellitus |
title_full | Analyzing the Association of Visceral Adipose Tissue Growth Differentiation Factor-15 and MicroRNA in Type 2 Diabetes Mellitus |
title_fullStr | Analyzing the Association of Visceral Adipose Tissue Growth Differentiation Factor-15 and MicroRNA in Type 2 Diabetes Mellitus |
title_full_unstemmed | Analyzing the Association of Visceral Adipose Tissue Growth Differentiation Factor-15 and MicroRNA in Type 2 Diabetes Mellitus |
title_short | Analyzing the Association of Visceral Adipose Tissue Growth Differentiation Factor-15 and MicroRNA in Type 2 Diabetes Mellitus |
title_sort | analyzing the association of visceral adipose tissue growth differentiation factor-15 and microrna in type 2 diabetes mellitus |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088550/ https://www.ncbi.nlm.nih.gov/pubmed/36918405 http://dx.doi.org/10.7570/jomes22010 |
work_keys_str_mv | AT roydipayan analyzingtheassociationofvisceraladiposetissuegrowthdifferentiationfactor15andmicrornaintype2diabetesmellitus AT purohitpurvi analyzingtheassociationofvisceraladiposetissuegrowthdifferentiationfactor15andmicrornaintype2diabetesmellitus AT khokharmanoj analyzingtheassociationofvisceraladiposetissuegrowthdifferentiationfactor15andmicrornaintype2diabetesmellitus AT modianupama analyzingtheassociationofvisceraladiposetissuegrowthdifferentiationfactor15andmicrornaintype2diabetesmellitus AT shuklaravindrakumargayaprasad analyzingtheassociationofvisceraladiposetissuegrowthdifferentiationfactor15andmicrornaintype2diabetesmellitus AT chaudharyramkaran analyzingtheassociationofvisceraladiposetissuegrowthdifferentiationfactor15andmicrornaintype2diabetesmellitus AT sankanagoudarshrimanjunath analyzingtheassociationofvisceraladiposetissuegrowthdifferentiationfactor15andmicrornaintype2diabetesmellitus AT sharmapraveen analyzingtheassociationofvisceraladiposetissuegrowthdifferentiationfactor15andmicrornaintype2diabetesmellitus |